X4 Pharmaceuticals, Inc. (XFOR) Debt by Year
X4 Pharmaceuticals, Inc. carried $75.0M in long-term debt against $217.0M in cash and equivalents at the end of fiscal year 2025. That is unchanged from the prior fiscal year. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters X4 Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
XFOR Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K |
|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $75.0M0.0% | $75.0M+37.4% | $54.6M+68.9% | $32.3M-2.5% | $33.1M-0.1% | $33.2M+65.9% | $20.0M+140.6% | $8.3M | N/A | N/A |
| Cash & Equivalents | $217.0M+289.7% | $55.7M-43.9% | $99.2M-18.5% | $121.7M+48.8% | $81.8M+3.9% | $78.7M-37.6% | $126.2M+1451.3% | $8.1M-69.5% | $26.7M+76.0% | $15.2M |
XFOR Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $75.0M0.0% | $75.0M0.0% | $75.0M0.0% | $75.0M0.0% | $75.0M0.0% | $75.0M+36.4% | $75.0M+37.4% | $75.0M+36.4% | $75.0M+130.8% | $55.0M+69.2% | $54.6M+68.9% | $55.0M+69.2% |
| Cash & Equivalents | $195.1M+397.4% | $216.9M+438.8% | $217.0M+289.7% | $69.6M-28.5% | $39.2M-73.4% | $40.3M-33.5% | $55.7M-43.9% | $97.4M-26.0% | $147.2M+7.9% | $60.5M-35.2% | $99.2M-18.5% | $131.6M+64.8% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More X4 Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was X4 Pharmaceuticals, Inc.'s long-term debt in fiscal year 2025?
X4 Pharmaceuticals, Inc. carried $75.0M in long-term debt against $217.0M in cash and equivalents at the end of fiscal year 2025.
How fast is X4 Pharmaceuticals, Inc.'s long-term debt growing?
X4 Pharmaceuticals, Inc. (XFOR) long-term debt was essentially unchanged year over year, at $75.0M in fiscal year 2025 against $75.0M the year before.
What was X4 Pharmaceuticals, Inc.'s long-term debt in the most recent quarter?
X4 Pharmaceuticals, Inc. (XFOR) reported $75.0M in long-term debt in Q2 2026. That is unchanged from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what X4 Pharmaceuticals, Inc. (XFOR) reported on that line in every period on record.